Your fact-checks will appear here
The Federal Trade Commission's enforcement actions against sellers of diabetes supplements that make unproven treatment claims from 2020 to 2021.
Courts and the Federal Trade Commission have repeatedly found that supplement marketers who claim to treat, prevent, or cure diabetes and diabetic neuropathy engage in deceptive advertising and must s...
The Federal Trade Commission has a sustained enforcement record against supplement sellers making unproven health claims—including actions specifically targeting products marketed for blood‑sugar cont...
Federal agencies have stepped up enforcement against companies marketing unproven diabetes and blood‑sugar remedies: the Federal Trade Commission sent cease‑and‑desist demands to 10 companies and the ...
A coordinated enforcement campaign by the Federal Trade Commission and the Food and Drug Administration has repeatedly targeted companies marketing dietary supplements that claim to prevent, treat, cu...
The Federal Trade Commission has repeatedly moved to shut down dietary-supplement marketers that advertise unproven diabetes treatments by sending cease-and-desist or warning letters ordering them to ...
Since 2020 the Federal Trade Commission has pursued a mix of administrative and enforcement measures against sellers of diabetes supplements that make unproven treatment claims: the agency issued ceas...